Utah Medical Products, Inc

Utah Medical Products is a U.S.-based medical device company that manufactures and markets specialty products used in obstetrics, gynecology, neonatal care, urology, and other clinical settings. Its business also includes OEM components and assemblies sold to other medical device and non-medical device customers, with operations and sales spanning the United States and selected international markets through direct and distributor channels.

31,7 %

57,1 %

29,3 %

−5,8 %

37.62

34.57

— Utah Medical Products, Inc
%
Specialty medical devices60% Finished clinical devices used in obstetrics, gynecology, neonatal care, urology and related procedures.
Filshie Clip System20% Tubal ligation and female sterilization products sold directly and through distributors.
OEM components and assemblies15% Custom-manufactured parts, molded components and assemblies sold to other manufacturers.
Biopharma pressure sensing products5% Pressure sensor and process control transducer configurations for biopharmaceutical applications.

UTMD sells to end-user clinical facilities, including hospitals and other medical/surgical care settings, as well as to...

  • Clinical facilitiesprimary

    Hospitals and end-user medical facilities buy finished devices for direct clinical use and procedural care.

  • Medical/surgical distributorsprimary

    Distributors buy and resell devices to clinical facilities, often providing storage and scheduled delivery.

  • OEM customersprimary

    Other device makers buy components, assemblies and molded parts for incorporation into their own products.

  • Biopharmaceutical manufacturerssecondary

    Biopharma customers buy pressure sensor and process control transducer configurations for manufacturing applications.

  • Non-medical industrial customerssecondary

    Selected non-medical customers buy custom components manufactured to specification.

UTMD sells directly in the United States and also serves Ireland, the UK, France, Canada, Australia and New Zealand...

  • United States is the largest market and a direct-sales base
  • Ireland is an important manufacturing location for Filshie devices
  • UK, France, Canada, Australia and New Zealand are direct OUS markets
  • China distribution creates exposure to shipment timing and tariffs
  • Cross-border sales and intercompany transfers affect margins and taxes

UTMD’s strategy centers on defending its core specialty device franchises, expanding selected product lines, and using...

01
Defend and support the Filshie Clip Systemshort-term

The product is a core branded franchise and an important contributor to the company’s clinical device mix.

02
Grow biopharma transducer salesmedium-term

Direct sales to biopharmaceutical manufacturers can diversify the customer base and use pre-qualified status.

03
Improve multinational operating efficiencymedium-term

Integrated manufacturing and distribution can lower friction across U.S. and OUS operations.

04
Return capital and pursue selective acquisitionslong-term

The company uses excess cash to support shareholder returns and opportunistic growth.

UTMD faces customer concentration risk in OEM and distributor relationships, along with exposure to tariffs, foreign...

high

Customer concentration in OEM sales

A large OEM customer can materially affect revenue when orders decline or are lost.

Scope
PendoTECH-related OEM sales
Materiality
high
high

Tariff exposure on imported components and devices

Import duties can increase manufacturing costs and reduce pricing flexibility.

Scope
U.S. imports from Ireland and other tariffed components
Materiality
high
high

Medical device regulatory and product liability risk

Clinical products require ongoing compliance, quality control and safety performance.

Scope
Specialty devices and the Filshie Clip System
Materiality
high
medium

Foreign exchange and international shipment timing

OUS sales are translated into USD and can be delayed by distributor decisions or currency moves.

Scope
UK, Europe, Canada, Australia, China and other OUS markets
Materiality
medium
Revenue recognition timing
Affects quarterly revenue comparability
Foreign currency translation
Affects reported revenue and operating trends
Intercompany eliminations
Affects gross sales presentation and consolidated expense structure
Tariff-related cost accounting
Affects cost of goods sold and gross margin

: 29/04/2026